Phase 1 clinical trial evaluating the safety and preliminary efficacy of autologous NK cells combined with T lymphocytes in patients with recurrent solid tumors
Authors: Kui-Jin Kim, NaHye Lee, Denis Nchang Che et al.
Publication: Cancer Immunology, Immunotherapy
Published: Sep 3, 2026
Source: Crossref